A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases

https://trepo.tuni.fi/handle/10024/145289

http://www.urn.fi/URN:NBN:fi:tuni-202301241693

1_s2.0_S0959804922018081_main.pdf (Tampereen yliopisto - Trepo)

Artikkeli

Thellenberg-Karlsson, Camilla ; Vjaters, Egils ; Kase, Marju ; Tammela, Teuvo ; Ojamaa, Kristiina ; Norming, Ulf ; Nyman, Claes ; Andersson, Sven-Olof ; Hublarovs, Oleg ; Marquez-Holmberg, Marcela ; Castellanos, Enrique ; Ullen, Anders ; Holmberg, Anders ; Nilsson, Sten ; Tampere University ; Clinical Medicine ; Department of Surgery

2023

Tallennettuna:

Ulkoasu

10
1034749

Kieli

englanti

Aiheet

3126 Surgery, anesthesiology, intensive care, radiology

Henkilökuntanäyttö